Study of Contraceptive Duration Described in the Information Materials of Prescription Drugs Requiring Contraception
- VernacularTitle:添付文書で避妊が求められている医薬品の各種資材における避妊期間の記載状況
- Author:
Aoi MATSUSHIMA
1
;
Takashi TOMITA
1
;
Erika SHIGITA
1
;
Hiroshi YOSHIKAWA
1
;
Tokue YANAGIDA
1
;
Hanae TAKAMATSU
1
;
Hiroaki MATSUO
1
Author Information
- Keywords: contraception; revised instruction for package insert; pregnancy; genetic toxicity
- From:Japanese Journal of Drug Informatics 2023;24(4):206-210
- CountryJapan
- Language:Japanese
- Abstract: Objective: In the instructions for package inserts (PI) of prescription drugs revised in June 2017, the section “persons with reproductive potential” was established under “precautions concerning patients with specific backgrounds.” The description rules associated with contraceptive duration were modified in these. In this study, we investigated descriptions of contraceptive duration in PI that were prepared based on the revised instructions, interview forms (IF), and other proper use materials (PM).Methods: We collected PI, IF, and PM of prescription drugs containing a new active ingredient approved from April 2017 to March 2022 for which the PI were prepared based on the revised instructions and investigated descriptions of PI, contraceptive duration, and its evidence in each information material.Results: Of the 181 drugs studied, 43.1 and 12.7% required females and males to use contraception during the period of drug consumption, respectively. Among these, the ratio of drugs that had descriptions of contraceptive duration were 15.4 and 0% for females and males at PI, respectively; 51.3 and 39.1% for female sand males at IF, respectively. Anticancer drugstended to describe contraceptive duration in the PM rather than PI or IF. For some drugs, there was no description of contraceptive duration in any of the materials. Contraceptive durations ranged from the period of administration of that drug to over a year for females and approximately one week to six months for males. The reasons for these contraceptive durations were diverse.Conclusion: Contraceptive information in the PI based on revised instructions were not sufficient for use by healthcare workers, even when the IF and PM were confirmed. These results suggest that there is a need for standardizing the descriptions, types of materials to be described, and choice of evidence for contraceptive duration.
